Ayurcann Holdings Corp. (CSE:AYUR)
Canada · Delayed Price · Currency is CAD 0.0050
0.00 (0.00%)
At close: Feb 27, 2026
Ayurcann Holdings Revenue
Ayurcann Holdings had revenue of 8.48M CAD in the quarter ending September 30, 2025, with 2.07% growth. This brings the company's revenue in the last twelve months to 31.28M, up 15.88% year-over-year. In the fiscal year ending June 30, 2025, Ayurcann Holdings had annual revenue of 31.11M with 23.66% growth.
Revenue (ttm)
31.28M
Revenue Growth
+15.88%
P/S Ratio
0.03
Revenue / Employee
n/a
Employees
n/a
Market Cap
973.52K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 31.11M | 5.95M | 23.66% |
| Jun 30, 2024 | 25.16M | 12.67M | 101.39% |
| Jun 30, 2023 | 12.49M | 3.11M | 33.09% |
| Jun 30, 2022 | 9.39M | 1.75M | 22.96% |
| Jun 30, 2021 | 7.63M | 7.02M | 1,147.68% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Adastra Holdings | 16.86M |
| Vencanna Ventures | 3.60M |
| Aequus Pharmaceuticals | 918.47K |
| Ovation Science | 63.82K |
| Genix Pharmaceuticals | 68.00 |
| Captor Capital | -1.18M |
Ayurcann Holdings News
- 3 months ago - AYURCANN REPORTS Q1 2026 SALES OF $14,638,697 - GlobeNewsWire
- 4 months ago - AYURCANN REPORTS FISCAL YEAR 2025 RECORD SALES OF $55,446,352 IN GROSS REVENUE, FEATURING 21% YEAR-OVER-YEAR INCREASE AND PROVIDES CORPORATE UPDATE - GlobeNewsWire
- 1 year ago - AYURCANN REPORTS ANOTHER RECORD SALES GROWTH IN Q2 2025 OF $13,363,509 - GlobeNewsWire
- 1 year ago - AYURCANN REPORTS ANOTHER RECORD SALES GROWTH IN Q1 2025 OF $14,760,268 AND PROVIDES CORPORATE UPDATE - GlobeNewsWire
- 1 year ago - AYURCANN TERMINATES BUSINESS COMBINATION - GlobeNewsWire
- 1 year ago - AYURCANN REPORTS FISCAL YEAR 2024 RECORD SALES OF $45,265,235 IN GROSS REVENUE, FEATURING ANOTHER 100% YEAR-OVER-YEAR INCREASE - GlobeNewsWire
- 1 year ago - Ayurcann Holdings Corp is entering into a business combination with Arogo Capital Acquisition Corp. and its subsidiaries at a combined enterprise value estimated to be U.S. $210 million. - GlobeNewsWire
- 1 year ago - AYURCANN REPORTS RECORD SALES IN Q3 2024 OF $11,655,360 FEATURING A 97% INCREASE IN GROSS REVENUE - GlobeNewsWire